Braskem A ADR earnings beat by $0.09, revenue topped estimates

Braskem A ADR (BAK) reported Q3 EPS of $0.083, beating estimates by $0.09, with revenue at $3.81B, exceeding expectations. The stock is down 43.78% over 3 months and 62.95% over 12 months. InvestingPro rates its financial health as 'fair performance'.

Original reporting
Published Nov 13, 2026, 12:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BAK
Bearish
medium confidence
Mentioned
$BAK
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BAKBearishMed
01

Why it matters

The earnings beat provides fresh data for traders to reassess valuation.

02

Market read

Earnings surprise may prompt short-term buying interest.

03

What to watch

Potential headwinds from commodity price volatility and currency fluctuations could offset the earnings beat.

Relevance 7/10Novelty 6/10Timing: after-hours

Background

Braskem A ADR is a Brazilian petrochemical company listed on NYSE as an ADR.

Company-level read

Ticker impact

$BAKBearishMedium confidence
Context

Braskem A ADR reported Q3 EPS of $0.083, beating estimates by $0.09 and revenue of $3.81B versus $3.55B consensus.

Expected impact

potential modest upside as market prices in the earnings beat

Evidence & confidence

The beat on both earnings and revenue provides fresh positive data, but the company is already down sharply over the past year, limiting upside.

Market effects

Chemicals sector may see slight lift from a major player beating expectations.

Brazilian and Latin American markets could react modestly.

Limited global impact; primarily relevant to investors in Braskem and related chemicals stocks.

Counterpoint

Given the steep decline over the past year, the beat may be already priced in, limiting upside.

Key entities

  • Braskem A ADR

    Brazilian petrochemical producer listed as ADR on NYSE.

Related articles

$BAKMed

Braskem Loss Hits US$189M as Creditors Wait

Braskem, a Brazilian resin producer, reported a R$1.07 billion (US$189 million) loss in Q3 2026, citing narrower spreads and high financing costs. Net revenue rose 13% to R$19.58 billion (US$3.46 billion). Creditors have not agreed to a debt deal, and auditor Deloitte noted material uncertainty about the company's ability to continue as a going concern.

$BAKMed

Braskem Q3 Earnings Call Highlights

Braskem (NYSE:BAK) is pursuing a capital structure solution with advisers and interested parties, according to CFO Carlos Brandão. The company is focused on reaching agreement on essential commercial terms. Braskem expects modest recovery in Q4 spreads, with increases forecasted for Brazil's polyethylene, polypropylene, and Mexico's polyethylene-ethane spreads. The company reported a BRL 3.2 billion provision balance for a geological event in Alagoas, with 99.9% of relocation completed.

$BAKMed

Braskem Loses US$189M as Debt Talks Drag On

Braskem, the largest resin producer in the Americas, reported a net loss of R$1.07 billion (US$189 million) in Q3 2026, reversing a profit from the previous quarter. The loss was driven by lower gross profit due to narrowed chemical and petrochemical spreads. The company's recurring EBITDA fell 63% to R$1.96 billion (US$347 million), while net revenue increased 13% year-over-year to R$19.58 billion (US$3.46 billion).

$BAKHigh

BRASKEM SA (BAK): Financial results for Q3 2026

BRASKEM SA (BAK) furnished an SEC Form 6-K — earnings release. CONTENTS 1. OPERATIONAL AND FINANCIAL INDICATORS 6 2. EXECUTIVE SUMMARY 3Q26 7 3. PERFORMANCE BY SEGMENT 3Q26 8 3.1 BRAZIL/SOUTH AMERICA 8 3.1.2 OVERVIEW 9 3.2 RENEWABLES OVERVIEW 13 3.3 UNITED STATES AND EUROPE 14 3.4 MEXICO 16 4. CONSOLIDATED FINANCIAL OVERVIEW 18 4.1 CONSOLIDA